Biotech takeover target Abivax sinks over 30% as cancer cases cloud trial data for bowel disease drug
A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.
Kategori: Jeopolitik
Haberin tamamını oku →
Gözlem Hattı Ana Sayfa
Hakkımızda | Gizlilik Politikası